Subgroup Analysis from a Phase 2, Single-Arm Trial of the Oral PI3Kd Inhibitor Linperlisib in Patients with Relapsed or Refractory Follicular Lymphoma
Tingyu Wang,Xiuhua Sun,Lihua Qiu,Hang Su,Junning Cao,Zhiming Li,Yuqin Song,Li Zhang,Dengju Li,Huijing Wu,Wei Zhang,Junmin Li,Keshu Zhou,Hui Zhou,Yu Yang,Zhifeng Li,Hong Cen,Zhen Cai,Zhihui Zhang,Weijun Fu,Jin Jie,Fei Li,Weixin Wu,Xuekui Gu,Weiliang Zhu,Lihong Liu,Zengjun Li,Shuhua Yi,Hanying Bao,Zusheng Xu,Lugui Qiu BLOOD（2023）
AI 理解论文
溯源树
样例
